Drugs Made Stock Forecast - Relative Strength Index
| DMAA Stock | 10.44 0.03 0.29% |
Drugs Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Drugs Made stock prices and determine the direction of Drugs Made In's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Drugs Made's historical fundamentals, such as revenue growth or operating cash flow patterns.
The relative strength index (RSI) of Drugs Made's stock price is about 69 suggesting that the stock is rather overbought by investors at this time. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Drugs, making its price go up or down. Momentum 69
Buy Stretched
Oversold | Overbought |
Using Drugs Made hype-based prediction, you can estimate the value of Drugs Made In from the perspective of Drugs Made response to recently generated media hype and the effects of current headlines on its competitors.
Drugs Made after-hype prediction price | USD 10.41 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Drugs Made to cross-verify your projections. Drugs Made Additional Predictive Modules
Most predictive techniques to examine Drugs price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Drugs using various technical indicators. When you analyze Drugs charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Relative Strength Index | Relative Strength Index | Trend |
| 69.29 | 69.29 |
| Check Drugs Made Volatility | Backtest Drugs Made | Information Ratio |
Drugs Made Trading Date Momentum
| On January 26 2026 Drugs Made In was traded for 10.44 at the closing time. The top price for the day was 10.45 and the lowest listed price was 10.41 . There was no trading activity during the period 0.0. Lack of trading volume on January 26, 2026 did not affect price variability. The overall trading delta against the current closing price is 0.29% . |
| Compare Drugs Made to competition |
Other Forecasting Options for Drugs Made
For every potential investor in Drugs, whether a beginner or expert, Drugs Made's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Drugs Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Drugs. Basic forecasting techniques help filter out the noise by identifying Drugs Made's price trends.Drugs Made Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Drugs Made stock to make a market-neutral strategy. Peer analysis of Drugs Made could also be used in its relative valuation, which is a method of valuing Drugs Made by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Drugs Made Market Strength Events
Market strength indicators help investors to evaluate how Drugs Made stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Drugs Made shares will generate the highest return on investment. By undertsting and applying Drugs Made stock market strength indicators, traders can identify Drugs Made In entry and exit signals to maximize returns.
Drugs Made Risk Indicators
The analysis of Drugs Made's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Drugs Made's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting drugs stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 0.0679 | |||
| Standard Deviation | 0.0942 | |||
| Variance | 0.0089 | |||
| Downside Variance | 0.0194 | |||
| Semi Variance | (0.01) | |||
| Expected Short fall | (0.12) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Drugs Made
The number of cover stories for Drugs Made depends on current market conditions and Drugs Made's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Drugs Made is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Drugs Made's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Drugs Made Short Properties
Drugs Made's future price predictability will typically decrease when Drugs Made's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Drugs Made In often depends not only on the future outlook of the potential Drugs Made's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Drugs Made's indicators that are reflective of the short sentiment are summarized in the table below.
| Short Percent Float | 0.0014 | |
| Shares Float | 25.2 M | |
| Short Percent | 0.0014 |
Check out Historical Fundamental Analysis of Drugs Made to cross-verify your projections. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is Diversified Capital Markets space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Drugs Made. If investors know Drugs will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Drugs Made listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Drugs Made In is measured differently than its book value, which is the value of Drugs that is recorded on the company's balance sheet. Investors also form their own opinion of Drugs Made's value that differs from its market value or its book value, called intrinsic value, which is Drugs Made's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Drugs Made's market value can be influenced by many factors that don't directly affect Drugs Made's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Drugs Made's value and its price as these two are different measures arrived at by different means. Investors typically determine if Drugs Made is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Drugs Made's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.